VULNERABILITY TO DRUG ABUSE--PREVALENCE OF DA RECEPTORS
VULNERABILITY TO DRUG ABUSE--PREVALENCE OF DA RECEPTORS
批准号:
2120911
负责人:
DAVID E COMINGS
金额:
$19.38万
依托单位国家:
美国
项目类别:
财政年份:
1994
资助国家:
美国
项目状态:
已结题
起止时间:
1994-06-01 至 1997-05-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Individuals appear to vary in their vulnerability to drug abuse.
The reward system in humans is composed of dopaminergic (DA)
neurons and the administration of addicting drugs results in the
stimulation of this system. A reasonable hypothesis for the
neurochemical basis of drug abuse is that vulnerable individuals
self medicate to compensate for defects in the dopaminergic reward
system. To investigate the possibility that variations in the
prevalence of different forms of the dopamine D2 receptor (DRD2)
gene in drug addicts may be involved in the vulnerability to drug
addiction, we determined the frequency of the DRD2 variants in
several hundred substance abusers. This showed a high correlation
between the frequency of the TaqI A1 variant and multisubstance
abuse, based upon the number of drugs on which more than $25 per
week were spent, (p= 0.006). Using the Defense Style Questionnaire,
drug addicts carrying the l haplotype, which is in linkage
disequilibrium with the D2A1 variant, showed much greater use of
immature defenses than non-1 carriers.
These preliminary studies support the concept that differences in
the prevalence of DA receptor variants play an important role in
fundamental personality traits that affect a person's vulnerability
to drug abuse, and other impulsive, compulsive, addictive
behaviors. To attempt to verify this association, we propose the
following studies on 200 male substance abusers, from the
Addictions Treatment Ward at the Jerry L. Pettis V.A. Hospital and
200 sex age, race, and ethnically matched controls: l) Genetic
testing of the D2A1, B1, C1 and haplotype variants of the DRD2
gene, 2) Genetic testing for variants of the dopamine D1, D3, D4
and D5 receptor genes and the dopamine transporter gene 3) Testing
of all genotyped subjects with the Diagnostic Interview Schedule,
MMP1, Addiction Severity Index, Defense Style Questionnaire and
Axis II Personality Index. 4) Statistical analysis to test for
possible correlations between the independent genetic variables,
personality variables and drug abuse.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
OB GENE IN HUMAN OBESITY
-
批准号:2882805
-
项目类别:
-
资助金额:$7.33万
-
财政年份:1998
-
负责人:DAVID E COMINGS
-
依托单位:
OB GENE IN HUMAN OBESITY
-
批准号:2449035
-
项目类别:
-
资助金额:$7.33万
-
财政年份:1998
-
负责人:DAVID E COMINGS
-
依托单位:
VULNERABILITY TO DRUG ABUSE--PREVALENCE OF DA RECEPTORS
-
批准号:2120910
-
项目类别:
-
资助金额:$20.38万
-
财政年份:1994
-
负责人:DAVID E COMINGS
-
依托单位:
VULNERABILITY TO DRUG ABUSE--PREVALENCE OF DA RECEPTORS
-
批准号:2120912
-
项目类别:
-
资助金额:$19.05万
-
财政年份:1994
-
负责人:DAVID E COMINGS
-
依托单位:
SMALL INSTRUMENT PROGRAM
-
批准号:3522912
-
项目类别:
-
资助金额:$1.76万
-
财政年份:1991
-
负责人:DAVID E COMINGS
-
依托单位:
SMALL INSTRUMENTATION PROGRAM
-
批准号:3524503
-
项目类别:
-
资助金额:$1.8万
-
财政年份:1990
-
负责人:DAVID E COMINGS
-
依托单位:
SMALL INSTRUMENTATION PROGRAM
-
批准号:3523408
-
项目类别:
-
资助金额:$2.15万
-
财政年份:1989
-
负责人:DAVID E COMINGS
-
依托单位:
SMALL INSTRUMENTATION PROGRAM
-
批准号:3522762
-
项目类别:
-
资助金额:$2.09万
-
财政年份:1988
-
负责人:DAVID E COMINGS
-
依托单位:
BIOMEDICAL RESEARCH SUPPORT
-
批准号:3515368
-
项目类别:
-
资助金额:$8.06万
-
财政年份:1987
-
负责人:DAVID E COMINGS
-
依托单位:
VERTICAL ROTOR AND HPLC SYSTEM
-
批准号:3523147
-
项目类别:
-
资助金额:$2.29万
-
财政年份:1987
-
负责人:DAVID E COMINGS
-
依托单位:
BIOMEDICAL RESEARCH SUPPORT
-
批准号:3515367
-
项目类别:
-
资助金额:$8.25万
-
财政年份:1986
-
负责人:DAVID E COMINGS
-
依托单位:
BIOMEDICAL RESEARCH SUPPORT
-
批准号:3515366
-
项目类别:
-
资助金额:$8.16万
-
财政年份:1985
-
负责人:DAVID E COMINGS
-
依托单位:
BIOMEDICAL RESEARCH SUPPORT
-
批准号:3515370
-
项目类别:
-
资助金额:$5.99万
-
财政年份:1979
-
负责人:DAVID E COMINGS
-
依托单位:
BIOMEDICAL RESEARCH SUPPORT
-
批准号:3515372
-
项目类别:
-
资助金额:$2.36万
-
财政年份:1979
-
负责人:DAVID E COMINGS
-
依托单位:
BIOMEDICAL RESEARCH SUPPORT
-
批准号:3515371
-
项目类别:
-
资助金额:$4.7万
-
财政年份:1979
-
负责人:DAVID E COMINGS
-
依托单位:
BIOMEDICAL RESEARCH SUPPORT
-
批准号:3515369
-
项目类别:
-
资助金额:$7.36万
-
财政年份:1979
-
负责人:DAVID E COMINGS
-
依托单位: